NCT03682445 is a NA clinical trial of exercise in Type2 Diabetes Mellitus, sponsored by Pamukkale University.

Who is sponsoring NCT03682445?

NCT03682445 is sponsored by Pamukkale University.

What drugs are being tested in NCT03682445?

Interventions in NCT03682445: exercise.

What condition does NCT03682445 study?

NCT03682445 studies Type2 Diabetes Mellitus, Exercise.

Is NCT03682445 still recruiting?

NCT03682445 is currently completed. Last updated 16 December 2020.

Last reviewed 2020-12-16 · How we verify

NCT03682445

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes Mellitus

Completed NA Last updated 16 December 2020

What this trial tests

NA trial testing exercise in Type2 Diabetes Mellitus in 60 participants. Completed in 14 December 2020.

Timeline

4 November 2019

Primary endpoint
1 December 2020

14 December 2020

Quick facts

Lead sponsor	Pamukkale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	60
Start date	4 November 2019
Primary completion	1 December 2020
Estimated completion	14 December 2020
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

exercise

Conditions studied

Type2 Diabetes Mellitus — all drugs for Type2 Diabetes Mellitus →
Exercise — all drugs for Exercise →

Sponsor

Pamukkale University

Who can join

Adults 35 to 55, any sex, with Type2 Diabetes Mellitus or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on metabolic parameters, physical measures, fitness level, body composition and miRNA-143 level in patients with type 2 diabetes mellitus.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery.
Pandey A, Ajgaonkar S, Jadhav N, Saha P, et al · · 2022 · cited 14× · PMID 36297381 · DOI 10.3390/ph15101269
Is isoenergetic high-intensity interval exercise superior to moderate-intensity continuous exercise for cardiometabolic risk factors in individuals with type 2 diabetes mellitus? A single-blinded randomized controlled study.
Findikoglu G, Altinkapak A, Yaylali GF. · · 2023 · cited 8× · PMID 36622777 · DOI 10.1080/17461391.2023.2167238

Verify or expand the search:

Other trials of exercise

Trials testing the same drug.

NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
NCT07442409 — The Effect of Ergonomics and Exercise Training on Musculoskeletal Disorders in Female Dairy Farmers · NA · recruiting
NCT07379801 — The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program · NA · recruiting

Other recruiting trials for Type2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07533604 — SnapDandCGMinType2Diabetes · NA · recruiting
NCT06961019 — Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets · NA · recruiting
NCT06497842 — Effort During Resistance Training in Type 2 Diabetes · NA · active not recruiting
NCT06257966 — A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type · Phase 3 · active not recruiting
NCT03647306 — Behavioral Chronotype: Impact on Sleep and Metabolism · NA · active not recruiting

Other Pamukkale University trials

Trials by the same sponsor.

NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03682445 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
Last refreshed: 16 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03682445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing